Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results 3

Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide delayed-release tablet made by 3D printing using Melt E…